Ph.D., Chief Medical Officer, Bionano Genomics
Biography
Alka Chaubey is double board-certified in clinical cytogenetics/genomics and clinical molecular genetics/genomics by the American Board of Medical Genetics and Genomics (ABMGG). She is a Fellow of the American College of Medical Genetics and Genomics (FACMG). She serves on the Board of Directors for the Cancer Genomics Consortium and was the Genetics Subdivision Nominating Committee representative of the Association of Molecular Pathologists (AMP). Dr Chaubey serves on the ACMG DEI committee and is a genomics enthusiast.
Session Abstract – PMWC 2022 Silicon Valley
Sequencing technologies are continuously improving, making it easier to obtain more in-depth molecular information than ever before. Emerging single-cell multi-omics sequencing technologies allow the capture of multiple modalities from a cell, including its epigenome, transcriptome, epitranscriptome, and proteome. This allows research into the heterogeneity of many biological mechanisms, and insights into complex molecular mechanisms that underpin disease.
Sessions:
- 4th Generation Sequencing Technologies & Genome Mapping Systems
- Barrett Bready, Nabsys
- Alka Chaubey, Bionano Genomics - Long-Read Sequencing Technologies
- Steve Turner, PacBio - Single Cell Genomics
- Michael Schnall-Levin, 10x Genomics - Spatial Transcriptomics
- Jason T. Gammack, Resolve Biosciences - Pathogen Identification
Session Chair: Charles Chiu, UCSF
- Todd Dickinson, Arc Bio
- Philip Stevens, Noscendo - ML/AI for Diagnosis & Prognosis
- Amrie Grammer, Ampel BioSolutions - Modern Technologies for Pathogen Identification + AI
Session Chair: Sivan Bercovici, Karius Dx - Proteogenomics
- Nigel Beard, Encodia - Advances Proteomics - Stratifying Cardiovascular Risk to Decrease Cost of Care
Session Chair: Roy Smythe, SomaLogic
- Matthias Kleinz, UPMC - Leveraging Immune System Diagnostics to Improve Disease Outcomes
Session Chair: Kathy Kamath, Serimmune, Inc
- Millennia Lytle, Mymee
- Noah Nasser, Serimmune, Inc - Evolving Alzheimer’s Disease Therapeutics with Neuro Diagnostic Therapies
Session Chair: Kevin Hrusovsky, Quanterix
- Charlotte Teunissen, Amsterdam UMC
- Henrik Zetterberg, University of Gothenburg
- Nicholas Ashton, University of Gothenburg - PMWC Showcase (NCI)
- Michael Cardone, Eutropics Pharmaceuticals
- Robert Meltzer, Fluent BioSciences
- Cynthia Taylor Lawley, Olink Proteomics
- Brian McKelligon, Akoya Biosciences
